SAN DIEGO–(BUSINESS WIRE)–Feb. 13, 2024– Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report fourth quarter and full year 2023 financial results on Tuesday, February 27, 2024, after the close of the U.S. financial markets. Acadia’s management team will also host a conference call and webcast on February 27, 2024, at 4:30 p.m. Eastern Time to discuss financial results and operations.
Ann: Comment on research report, page-296
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.81 |
Change
0.200(1.47%) |
Mkt cap ! $1.784B | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.00 | $13.51 | $2.894M | 209.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 142 | $13.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.82 | 641 | 13 |
View Market Depth
| Last trade - 15.36pm 13/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |